Product
CarCyDex
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Untreated Transplant-eligible Patients With Symptomatic MM to Evaluate the Benefit of Upfront ASCTStatus: Active (not recruiting), Estimated PCD: 2019-11-01